How The Market For Tesaro's Niraparib Plays Out Following Early FDA Approval

By: via Benzinga
TESARO Inc (NASDAQ: TSRO)'s niraparib has received FDA approval, ahead of its Prescription Drug User Fee Act date of June ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.